PNC Financial Services Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Buy
56,588
+18,701
+49% +$516K ﹤0.01% 1024
2025
Q1
$1.07M Buy
37,887
+10,761
+40% +$305K ﹤0.01% 1137
2024
Q4
$1.13M Sell
27,126
-6,873
-20% -$286K ﹤0.01% 1118
2024
Q3
$2.27M Sell
33,999
-7,236
-18% -$484K ﹤0.01% 877
2024
Q2
$4.9M Buy
41,235
+4,733
+13% +$562K ﹤0.01% 652
2024
Q1
$3.89M Buy
36,502
+9,612
+36% +$1.02M ﹤0.01% 714
2023
Q4
$2.67M Sell
26,890
-809
-3% -$80.5K ﹤0.01% 794
2023
Q3
$2.86M Sell
27,699
-2,210
-7% -$228K ﹤0.01% 757
2023
Q2
$3.63M Buy
29,909
+244
+0.8% +$29.6K ﹤0.01% 723
2023
Q1
$4.56M Sell
29,665
-9,845
-25% -$1.51M ﹤0.01% 660
2022
Q4
$7.1M Buy
39,510
+48
+0.1% +$8.62K 0.01% 549
2022
Q3
$4.67M Buy
39,462
+10,526
+36% +$1.24M ﹤0.01% 629
2022
Q2
$4.13M Buy
28,936
+4,807
+20% +$687K ﹤0.01% 683
2022
Q1
$4.16M Buy
24,129
+4,122
+21% +$710K ﹤0.01% 720
2021
Q4
$5.08M Sell
20,007
-3,706
-16% -$941K ﹤0.01% 699
2021
Q3
$9.13M Buy
23,713
+7,943
+50% +$3.06M 0.01% 519
2021
Q2
$3.71M Buy
15,770
+874
+6% +$205K ﹤0.01% 736
2021
Q1
$1.95M Sell
14,896
-200
-1% -$26.2K ﹤0.01% 890
2020
Q4
$1.58M Buy
15,096
+3,442
+30% +$360K ﹤0.01% 938
2020
Q3
$826K Buy
11,654
+699
+6% +$49.5K ﹤0.01% 1130
2020
Q2
$703K Buy
10,955
+6,727
+159% +$432K ﹤0.01% 1195
2020
Q1
$127K Buy
4,228
+71
+2% +$2.13K ﹤0.01% 2078
2019
Q4
$81K Buy
4,157
+1,752
+73% +$34.1K ﹤0.01% 2610
2019
Q3
$38K Buy
2,405
+192
+9% +$3.03K ﹤0.01% 3058
2019
Q2
$31K Buy
+2,213
New +$31K ﹤0.01% 3167